SCHEMBL8071307

SCHEMBL8071307

C=C(Nc1cccc(Cl)c1)c1cnc(N)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 1/20 0.46
P4HTM Q9NXG6 1/20 0.45
GRM4 Q14833 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
IDO1 P14902 1/20 0.42
HDAC6 Q9UBN7 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
HTR3A P46098 1/20 0.41
HTR3D Q70Z44 1/20 0.41
HTR3C Q8WXA8 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
HDAC3 O15379 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8071311 0.81 MEN1 (0.43) P4HTMGRM4MEN1KMT2AALDH1A1
SCHEMBL8083748 0.79 EGFR (0.43) P4HTMMEN1KMT2AALDH1A1LMNA
SCHEMBL8088414 0.79 KMT2A (0.41) P4HTMMEN1KMT2AALDH1A1LMNA
SCHEMBL8078603 0.76 VNN1 (0.48) P4HTMMEN1KMT2AALDH1A1LMNA
SCHEMBL8081787 0.71 CNR1 (0.48) P4HTMMEN1KMT2AALDH1A1LMNA
SCHEMBL8082051 0.70 HCAR3 (0.49) P4HTMMEN1KMT2AALDH1A1MAPT
SCHEMBL3639325 0.69 P4HTM (0.64) P4HTMGRM4MEN1KMT2AALDH1A1
SCHEMBL8086323 0.69 KDM4E (0.54) P4HTMGRM4MEN1KMT2AALDH1A1
SCHEMBL8086591 0.69 CNR2 (0.56) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL8081028 0.69 HCAR3 (0.51) P4HTMMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009016088-A1 THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2009-02-05 WO disclosed